Annual ROA:
-46.37%+5.13%(+9.96%)Summary
- As of today, TVTX annual return on assets is -46.37%, with the most recent change of +5.13% (+9.96%) on December 31, 2024.
- During the last 3 years, TVTX annual ROA has fallen by -20.35% (-78.21%).
- TVTX annual ROA is now -234.06% below its all-time high of 34.59%, reached on December 31, 2015.
Performance
TVTX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROA:
-30.69%+8.78%(+22.24%)Summary
- As of today, TVTX quarterly return on assets is -30.69%, with the most recent change of +8.78% (+22.24%) on June 30, 2025.
- Over the past year, TVTX quarterly ROA has increased by +22.97% (+42.81%).
- TVTX quarterly ROA is now -204.74% below its all-time high of 29.30%, reached on December 31, 2015.
Performance
TVTX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
TVTX ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | +10.0% | +42.8% |
3Y3 Years | -78.2% | -4.1% |
5Y5 Years | -113.2% | -108.1% |
TVTX ROA Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | -78.2% | +10.0% | at high | +42.8% |
5Y | 5-Year | -113.2% | +10.0% | -148.7% | +42.8% |
All-Time | All-Time | -234.1% | +98.2% | -204.7% | +99.5% |
TVTX ROA History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | -30.69%(+22.2%) |
Mar 2025 | - | -39.47%(+23.6%) |
Dec 2024 | -46.37%(+10.0%) | -51.68%(+1.1%) |
Sep 2024 | - | -52.23%(+2.7%) |
Jun 2024 | - | -53.66%(-2.9%) |
Mar 2024 | - | -52.14%(-11.2%) |
Dec 2023 | -51.50%(-12.6%) | -46.89%(+0.8%) |
Sep 2023 | - | -47.28%(-0.0%) |
Jun 2023 | - | -47.26%(-8.2%) |
Mar 2023 | - | -43.68%(-5.7%) |
Dec 2022 | -45.74%(-75.8%) | -41.33%(-15.3%) |
Sep 2022 | - | -35.85%(-21.6%) |
Jun 2022 | - | -29.47%(-13.4%) |
Mar 2022 | - | -25.98%(-5.9%) |
Dec 2021 | -26.02%(+6.9%) | -24.54%(+29.6%) |
Sep 2021 | - | -34.88%(-2.7%) |
Jun 2021 | - | -33.97%(-0.5%) |
Mar 2021 | - | -33.80%(-25.9%) |
Dec 2020 | -27.95%(-28.5%) | -26.84%(-117.5%) |
Sep 2020 | - | -12.34%(+16.3%) |
Jun 2020 | - | -14.75%(+12.4%) |
Mar 2020 | - | -16.84%(+24.7%) |
Dec 2019 | -21.75%(-35.4%) | -22.35%(-22.5%) |
Sep 2019 | - | -18.25%(+15.9%) |
Jun 2019 | - | -21.70%(-8.0%) |
Mar 2019 | - | -20.09%(-16.9%) |
Dec 2018 | -16.06%(-48.6%) | -17.19%(+15.7%) |
Sep 2018 | - | -20.40%(-37.0%) |
Jun 2018 | - | -14.89%(-14.5%) |
Mar 2018 | - | -13.01%(-15.1%) |
Dec 2017 | -10.81% | -11.30%(-17.6%) |
Sep 2017 | - | -9.61%(+27.3%) |
Jun 2017 | - | -13.21%(+0.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2017 | - | -13.24%(-46.6%) |
Dec 2016 | -8.63%(-124.9%) | -9.03%(-12.3%) |
Sep 2016 | - | -8.04%(-139.7%) |
Jun 2016 | - | 20.26%(+8.2%) |
Mar 2016 | - | 18.72%(-36.1%) |
Dec 2015 | 34.59%(+124.3%) | 29.30%(+5.6%) |
Sep 2015 | - | 27.74%(+305.8%) |
Jun 2015 | - | -13.48%(-5516.7%) |
Mar 2015 | - | -0.24%(+99.8%) |
Dec 2014 | -142.26%(+53.0%) | -100.39%(+7.1%) |
Sep 2014 | - | -108.05%(+26.0%) |
Jun 2014 | - | -145.97%(+57.8%) |
Mar 2014 | - | -346.24%(-7.2%) |
Dec 2013 | -302.53%(+88.1%) | -322.98%(+60.3%) |
Sep 2013 | - | -812.90%(+59.4%) |
Jun 2013 | - | -2001.97%(+16.1%) |
Mar 2013 | - | -2385.44%(+62.2%) |
Dec 2012 | -2533.62%(-373.7%) | -6303.24%(-1644.2%) |
Nov 2011 | - | -361.39%(+10.1%) |
Aug 2011 | - | -401.91%(+12.8%) |
May 2011 | - | -460.65%(+10.7%) |
Feb 2011 | -534.88%(+10.2%) | -515.70%(+8.4%) |
Nov 2010 | - | -563.04%(+2.5%) |
Aug 2010 | - | -577.59%(-0.5%) |
May 2010 | - | -574.79%(+2.8%) |
Feb 2010 | -595.74%(+21.9%) | -591.10%(+1.3%) |
Nov 2009 | - | -598.74%(-10.1%) |
Aug 2009 | - | -543.57%(-17.4%) |
May 2009 | - | -463.11%(-23.3%) |
Feb 2009 | -762.50% | -375.51%(-71.5%) |
Nov 2008 | - | -218.92%(-68.4%) |
Aug 2008 | - | -130.00%(-91.2%) |
May 2008 | - | -68.00% |
FAQ
- What is Travere Therapeutics, Inc. annual return on assets?
- What is the all-time high annual ROA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual ROA year-on-year change?
- What is Travere Therapeutics, Inc. quarterly return on assets?
- What is the all-time high quarterly ROA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly ROA year-on-year change?
What is Travere Therapeutics, Inc. annual return on assets?
The current annual ROA of TVTX is -46.37%
What is the all-time high annual ROA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual return on assets is 34.59%
What is Travere Therapeutics, Inc. annual ROA year-on-year change?
Over the past year, TVTX annual return on assets has changed by +5.13% (+9.96%)
What is Travere Therapeutics, Inc. quarterly return on assets?
The current quarterly ROA of TVTX is -30.69%
What is the all-time high quarterly ROA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly return on assets is 29.30%
What is Travere Therapeutics, Inc. quarterly ROA year-on-year change?
Over the past year, TVTX quarterly return on assets has changed by +22.97% (+42.81%)